Trevor Resnick
Neurology with Special Qualifications in Child Neurology · Miami, FLNPI 1780641381
Payments from drug & device makers
$313,426in general payments, 2019–2025
Across 747 payments — averaging $419.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$178K
- UCB, Inc.$35K
- Mallinckrodt Enterprises LLC$28K
- Sunovion Pharmaceuticals Inc.$19K
- Mallinckrodt Hospital Products Inc.$12K
- Catalyst Pharmaceuticals, Inc.$8K
- plus $33K from 29 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 134 | $177,787 |
| UCB, Inc. | 130 | $35,380 |
| Mallinckrodt Enterprises LLC | 27 | $27,714 |
| Sunovion Pharmaceuticals Inc. | 61 | $19,219 |
| Mallinckrodt Hospital Products Inc. | 6 | $11,508 |
| Catalyst Pharmaceuticals, Inc. | 12 | $8,392 |
| Supernus Pharmaceuticals, Inc. | 92 | $7,954 |
| SK Life Science, Inc. | 25 | $5,281 |
| UCB SA | 10 | $4,959 |
| Aquestive Therapeutics, Inc. | 21 | $3,288 |
| Hikma Pharmaceuticals USA | 2 | $3,000 |
| Azurity Pharmaceuticals, Inc. | 5 | $2,548 |
| Jazz Pharmaceuticals Inc. | 52 | $1,875 |
| Otter Pharmaceuticals, LLC | 1 | $1,338 |
| Neurelis, Inc. | 58 | $811 |
| Livanova USA, Inc. | 17 | $464 |
| Sumitomo Pharma America, Inc. | 15 | $368 |
| Corium, LLC | 13 | $300 |
| Ironshore Pharmaceuticals Inc. | 15 | $243 |
| Immedica Pharma US, Inc. | 6 | $140 |
| Greenwich Biosciences, Inc. | 7 | $131 |
| Biocodex, Inc. | 4 | $127 |
| Aprecia Pharmaceuticals, LLC | 7 | $113 |
| Biogen | 5 | $110 |
| Tris Pharma Inc | 6 | $82 |
| Zogenix Inc. | 2 | $49 |
| Aucta Pharmaceuticals, Inc. | 2 | $47 |
| Novartis | 3 | $45 |
| NS Pharma, Inc. | 2 | $29 |
| AbbVie | 1 | $28 |
| Vertical Pharmaceuticals, LLC | 2 | $27 |
| Acadia Pharmaceuticals Inc | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| Piramal Critical Care | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$313,426 in reported general payments places this provider in the 85th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Other neurology with special qualifications in child neurology in Miami
- Ian MillerMiami$1.1M
- Migvis MonduyMiami$455K
- Paula SchleiferMiami$394K
- Anuj JayakarMiami$361K
- Matt LallasMiami$339K
- Nelson SanchezMiami$255K
- Elza VasconcellosMiami$245K
- Marytery FajardoMiami$119K
- Fernando GalanMiami$103K
- Wilson Heredia NunezMiami$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.